Breaking News Instant updates and real-time market news.

SFTBF

SoftBank

$0.00

(0.00%)

, WE

We Company

$0.00

(0.00%)

12:38
10/23/19
10/23
12:38
10/23/19
12:38

WeWork's Claure tells staff layoffs are in the works, Reuters says

Marcelo Claure, WeWork's (WE) new executive chairman, told staff in a memo that layoffs were in the works at the company following a $9.5B rescue financing deal with SoftBank (SFTBF), Reuters reports. "Yes, there will be layoffs - I don't know how many - and yes, we have to right-size the business to achieve positive free cash flow and profitability," Claure, who serves as SoftBank's chief operating officer, wrote in the memo. The executive chairman also said in the memo that SoftBank was using WeWork to "reimagine" its headquarters in Tokyo, the report notes. Reference Link

SFTBF

SoftBank

$0.00

(0.00%)

WE

We Company

$0.00

(0.00%)

SFTBF SoftBank
$0.00

(0.00%)

12/12/18
RBCM
12/12/18
NO CHANGE
Target $230
RBCM
Outperform
Nvidia price target lowered to $230 from $260 at RBC Capital
RBC Capital analyst Mitch Steves lowered his price target on Nvidia (NVDA) to $230 after yesterday's report that Softbank (SFTBF) is exploring the sale of its stake in the company early next year. The analyst believes that in the near-term, the speculation is a negative since Softbank has "solid information on overall Data Center trends". Steves maintains his Outperform rating however, stating that a number of long-only investment managers have not participated in the run-up of the stock price. The analyst adds that Nvidia's long-term investment story around "AI/VR/AR/Autonomous" driving remains intact.
02/28/19
BTIG
02/28/19
NO CHANGE
Target $60
BTIG
Buy
SoftBank price target raised to $60 from $50 at BTIG
BTIG analyst Walter Piecyk raised his price target on SoftBank (SFTBY) to $60 and kept his Buy rating, citing his "better understanding" of the previously acquired ARM Holdings business which warrants a higher multiple. The analyst also sees a major catalyst coming in the "imminent decision" around Sprint (S) / T-Mobile (TMUS) deal, which could amount to additional $14 price target impact on Softbank shares.
WE We Company
$0.00

(0.00%)

09/10/19
09/10/19
NO CHANGE

We Company IPO is 'full speed ahead,' CNBC reports
The initial public offering of We Company is moving "full speed ahead" despite reports of the valuation reductions, CNBC's David Faber reports, citing sources close to the situation.

TODAY'S FREE FLY STORIES

GDDY

GoDaddy

$68.29

0.195 (0.29%)

07:58
11/19/19
11/19
07:58
11/19/19
07:58
Conference/Events
GoDaddy management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 03

    Dec

  • 09

    Dec

ZEAL

Zealand Pharma

$36.13

2.7 (8.08%)

07:57
11/19/19
11/19
07:57
11/19/19
07:57
Downgrade
Zealand Pharma rating change  »

Zealand Pharma downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VTR

Ventas

$58.35

0.1 (0.17%)

07:57
11/19/19
11/19
07:57
11/19/19
07:57
Upgrade
Ventas rating change  »

Ventas upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FRPT

Freshpet

$54.47

-0.81 (-1.47%)

07:56
11/19/19
11/19
07:56
11/19/19
07:56
Conference/Events
Freshpet management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

HD

Home Depot

$238.98

1.64 (0.69%)

07:54
11/19/19
11/19
07:54
11/19/19
07:54
Recommendations
Home Depot analyst commentary  »

Home Depot selloff after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 11

    Dec

DAVA

Endava

$44.12

0.12 (0.27%)

07:53
11/19/19
11/19
07:53
11/19/19
07:53
Earnings
Endava raises FY20 adj. EPS view to GBP0.86-GBP0.89 from GBP0.85-GBP0.88 »

Cuts FY20 revenue view to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

  • 26

    Nov

EURN

Euronav NV

$10.81

-0.18 (-1.64%)

07:53
11/19/19
11/19
07:53
11/19/19
07:53
Syndicate
Euronav NV 3.75M share Secondary priced at $10.44 »

UBS acted as sole book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DAVA

Endava

$44.12

0.12 (0.27%)

07:51
11/19/19
11/19
07:51
11/19/19
07:51
Earnings
Endava sees Q2 adj. EPS GBP0.21-GBP0.22 »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

  • 26

    Nov

FORM

FormFactor

$22.97

-0.24 (-1.03%)

07:51
11/19/19
11/19
07:51
11/19/19
07:51
Conference/Events
FormFactor management to meet with B. Riley FBR »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

EFX

Equifax

$139.44

1 (0.72%)

07:50
11/19/19
11/19
07:50
11/19/19
07:50
Hot Stocks
Equifax extends relationship with NCTUE »

Equifax has extended its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DAVA

Endava

$44.12

0.12 (0.27%)

07:49
11/19/19
11/19
07:49
11/19/19
07:49
Earnings
Endava reports Q1 adj. EPS GBP0.24 vs. GBP0.17 last year »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

  • 26

    Nov

ANSS

Ansys

$238.67

3.63 (1.54%)

07:48
11/19/19
11/19
07:48
11/19/19
07:48
Recommendations
Ansys analyst commentary  »

Ansys price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 02

    Dec

  • 11

    Dec

HP

Helmerich & Payne

$38.84

-1.72 (-4.24%)

07:48
11/19/19
11/19
07:48
11/19/19
07:48
Downgrade
Helmerich & Payne rating change  »

Helmerich & Payne…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TH

Target Hospitality

$4.24

-0.26 (-5.78%)

07:48
11/19/19
11/19
07:48
11/19/19
07:48
Downgrade
Target Hospitality rating change  »

Target Hospitality…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRRK

Scholar Rock

$7.18

-0.42 (-5.53%)

07:47
11/19/19
11/19
07:47
11/19/19
07:47
Hot Stocks
Scholar Rock announces preliminary PK, PD data from TOPAZ trial of SRK-015 »

Scholar Rock announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JEC

Jacobs Engineering

$93.70

-0.62 (-0.66%)

07:47
11/19/19
11/19
07:47
11/19/19
07:47
Hot Stocks
Jacobs Engineering awarded $216.6M contract by U.S. FEDSIM »

Jacobs was selected by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Nov

  • 10

    Dec

FOR

Forestar Group

$20.04

-0.21 (-1.04%)

07:46
11/19/19
11/19
07:46
11/19/19
07:46
Conference/Events
Forestar Group management to meet with B. Riley FBR »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

MDCO

The Medicines Co.

$58.66

6.74 (12.98%)

, NVS

Novartis

$90.28

0.26 (0.29%)

07:46
11/19/19
11/19
07:46
11/19/19
07:46
Periodicals
Novartis holds talks about potential acquisition of Medicines Co, Bloomberg says »

Medicines Co. (MDCO) has…

MDCO

The Medicines Co.

$58.66

6.74 (12.98%)

NVS

Novartis

$90.28

0.26 (0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

ACHN

Achillion

$6.26

0.005 (0.08%)

07:44
11/19/19
11/19
07:44
11/19/19
07:44
Hot Stocks
Achillion granted EMA PRIME designation for danicopan for PNH treatment »

Achillion Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANET

Arista Networks

$192.91

0.38 (0.20%)

07:43
11/19/19
11/19
07:43
11/19/19
07:43
Initiation
Arista Networks initiated  »

Arista Networks initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 09

    Dec

  • 09

    Dec

MYOV

Myovant Sciences

$6.02

-0.14 (-2.27%)

07:43
11/19/19
11/19
07:43
11/19/19
07:43
Hot Stocks
Myovant Sciences says primary efficacy endpoint met in Phase 3 HERO study »

Myovant Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MXL

MaxLinear

$19.84

-0.2 (-1.00%)

07:42
11/19/19
11/19
07:42
11/19/19
07:42
Upgrade
MaxLinear rating change  »

MaxLinear upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTNT

Fortinet

$103.80

2.31 (2.28%)

07:41
11/19/19
11/19
07:41
11/19/19
07:41
Recommendations
Fortinet analyst commentary  »

Fortinet price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 05

    Dec

  • 06

    Dec

  • 09

    Dec

  • 12

    Dec

OPGN

OpGen

$1.11

0.04 (3.76%)

07:41
11/19/19
11/19
07:41
11/19/19
07:41
Hot Stocks
OpGen says products in development to address 'urgent threat' pathogens »

OpGen announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:40
11/19/19
11/19
07:40
11/19/19
07:40
General news
Treasury Market Outlook: trading was pretty quiet overnight »

Treasury Market Outlook:…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.